Emily Felder is named as a lobbyist on federal disclosure filings for 49 clients through Brownstein Hyatt Farber Schreck, LLP. The most recent filing naming them posted in November 2026. Issues reported include Health Issues, Pharmacy, Veterans and Tariff (miscellaneous tariff bills).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| SUFFOLK PRIMARY HEALTH, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2026 | Medicare/Medicaid |
| CENCORA, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| BECTON, DICKINSON AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| STATE COLLECTION SERVICE, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Financial Institutions/Investments/Securities, Health Issues |
| SKILLFUL COMMUNICATIONS, INC. DBA BIG INTERVIEW | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Labor Issues/Antitrust/Workplace |
| MODERNA US INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Foreign Relations, Health Issues |
| TOLMAR, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy |
| NOVARTIS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| SOLVD HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ESO SOLUTIONS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Science/Technology, Health Issues |
| LIFEPOINT HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| KYVERNA THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| CENTENE CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| JOHNSON & JOHNSON SERVICES, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues, Tariff (miscellaneous tariff bills) |
| FERRING PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Trade (domestic/foreign), Health Issues |
| EMERGENCY NURSES ASSOCIATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ELI LILLY AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| EDERA L3C | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Science/Technology, Consumer Issues/Safety/Products |
| CONSENSUS CLOUD SOLUTIONS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Medical/Disease Research/Clinical Labs |
| SNAP DIAGNOSTICS, LLP | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Pharmacy |
| TAPESTRYHEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ASANA VOICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| TEXAS CHILDREN'S HOSPITAL | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ARDENT HEALTH SERVICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Government Issues |
| UNIVERSITY OF COLORADO HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| VALLEY CHILDREN'S HEALTHCARE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Education, Health Issues |
| ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Veterans, Health Issues |
| THE JEWISH FEDERATIONS OF NORTH AMERICA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| NATIONAL MENTOR HOLDINGS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2026 | Health Issues |
| RELX INC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2026 | Health Issues |
| GRINDR LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Science/Technology, Health Issues |
| MUSCLESOUND, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| CLEAR | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Aviation/Airlines/Airports |
| DEACON HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| PIERRE FABRE PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Pharmacy |
| GRANICUS, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2025 | Science/Technology |
| CINNAMON HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2025 | Veterans, Health Issues |
| WALGREEN CO. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2025 | Pharmacy |
| GLYTEC, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2025 | Health Issues |
| LEARNED HAND | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Science/Technology |
| THE FEDERATION OF STATE MEDICAL BOARDS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Health Issues |
| PIM BRANDS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Food Industry (safety, labeling, etc.), Health Issues |
| PARTICLE HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Health Issues |
| SPARK THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 39 | 1 |
| 2025 | 40 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 2 | $1K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Emily Felder. See the Capitol Clarity rankings and method.